Detalles de la búsqueda
1.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271158
2.
Incidence, Clinical Characteristics, and Predictors of Cardiovascular Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
Oncologist
; 27(5): e410-e419, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35348766
3.
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.
BMC Cancer
; 22(1): 964, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076179
4.
Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer.
Oncologist
; 25(3): e536-e544, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32162801
5.
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1177-1187, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32140762
6.
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Cancer Immunol Immunother
; 69(7): 1189, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32347358
7.
Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab.
Oncologist
; 23(11): 1358-1365, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934411
8.
Observational study of chemotherapy-induced Clostridium difficile infection in patients with lung cancer.
Int J Clin Oncol
; 23(6): 1046-1051, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29876691
9.
Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (ALK)-positive lung cancer and multiple brain metastases.
Cancer Rep (Hoboken)
; 7(2): e1981, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212894
10.
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060.
JTO Clin Res Rep
; 5(4): 100655, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706978
11.
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.
Adv Ther
; 40(11): 4928-4944, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715851
12.
Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge.
Thorac Cancer
; 14(31): 3140-3146, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37699787
13.
Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment.
Sci Rep
; 12(1): 3669, 2022 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35256688
14.
Nivolumab Retreatment in Non-Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L).
Clin Cancer Res
; : OF1-OF7, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35762926
15.
Association between immune-related adverse event timing and treatment outcomes.
Oncoimmunology
; 11(1): 2017162, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35003896
16.
Prospective Multicenter Study of Chemotherapy-Induced Clostridium (Clostridioides) difficile Infection in Patients With Lung Cancer: North Japan Lung Cancer Study Group Trial 1204.
Front Oncol
; 11: 685320, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34336670
17.
Serial 6-month change in forced vital capacity predicts subsequent decline and mortality in Japanese patients with newly diagnosed idiopathic pulmonary fibrosis.
Respir Investig
; 59(3): 335-341, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33551330
18.
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With EGFR T790M-Mutated Non-Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor: West Japan Oncology Group 8715L Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 7(3): 386-394, 2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33410885
19.
Gene expression signatures as candidate biomarkers of response to PD-1 blockade in non-small cell lung cancers.
PLoS One
; 16(11): e0260500, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843570
20.
Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer.
Cancer Med
; 10(14): 4796-4804, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34121358